Immunicon's Unattributed VC - II Round

Immunicon raised a round of funding on September 07, 2000.

Immunicon is developing proprietary cell- and molecular-based human diagnostic products with an initial focus on cancer disease management.…

Articles about Immunicon's Unattributed VC - II Round: